Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology

Digestive Diseases and Sciences

Volumn 60, Issue 8, 2015, Pages 2523-2528

  Corey, Kathleen E ^a,d   Misdraji, Joseph ^a,d   Gelrud, Lou ^b   King, Lindsay Y ^a   Zheng, Hui ^a,d   Malhotra, Atul ^c   Chung, Raymond T ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Bon Secours Richmond Health System   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Fibrosis; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Obstructive sleep apnea

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CAUCASIAN; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SELF REPORT; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; BLOOD; COMORBIDITY; LIVER; LIVER CIRRHOSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; SLEEP APNEA, OBSTRUCTIVE;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; COMORBIDITY; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; SLEEP APNEA, OBSTRUCTIVE;

EID: 84937514770     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-015-3650-8     Document Type: Article

References (30)

1. Charlton M. Cirrhosis and liver failure in nonalcoholic fatty liver disease: molehill or mountain? Hepatology. 2008;47:1431–1433.
2. Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675–1685.
3. Botros N, Concato J, Mohsenin V, Selim B, Doctor K, et al. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med. 2009;122:1122–1127.
4. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51:1972–1978.
5. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med. 2001;164:1910–1913.
6. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735–741.
7. Steiropoulos P, Tsara V, Nena E, Fitili C, Kataropoulou M, et al. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest. 2007;132:843–851.
8. Harsch IA, Schahin SP, Radespiel-Troger M, Weintz O, Jahreiss H, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004;169:156–162.
9. Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, et al. Chronic intermittent hypoxia predisposes to liver injury. Hepatology. 2007;45:1007–1013.
10. Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol. 2007;293:G871–G877.
11. Lin QC, Chen LD, Chen GP, et al. Association between nocturnal hypoxia and liver injury in the setting of nonalcoholic fatty liver disease. Sleep Breath. 2014;19:273–280.
12. Norman D, Bardwell WA, Arosemena F, Nelesen R, Mills PJ, et al. Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep. 2008;31:121–126.
13. Byrne TJ, Parish JM, Somers V, Aqel BA, Rakela J. Evidence for liver injury in the setting of obstructive sleep apnea. Ann Hepatol. 2012;11:228–231.
14. Jouet P, Sabate JM, Maillard D, Msika S, Mechler C, et al. Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective study. Obes Surg. 2007;17:478–485.
15. Ulitsky A, Ananthakrishnan AN, Komorowski R, Wallace J, Surapaneni SN, et al. A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients. Obes Surg. 2010;20:685–691.
16. Tanne F, Gagnadoux F, Chazouilleres O, Fleury B, Wendum D, et al. Chronic liver injury during obstructive sleep apnea. Hepatology. 2005;41:1290–1296.
17. Aron-Wisnewsky J, Minville C, Tordjman J, Levy P, Bouillot JL, et al. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol. 2012;56:225–233.
18. Mishra P, Nugent C, Afendy A, Bai C, Bhatia P, et al. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Liver Int. 2008;28:1080–1086.
19. Daltro C, Cotrim HP, Alves E, de Freitas LA, Araujo L, et al. Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence? Obes Surg. 2010;20:1536–1543.
20. Kallwitz ER, Herdegen J, Madura J, Jakate S, Cotler SJ. Liver enzymes and histology in obese patients with obstructive sleep apnea. J Clin Gastroenterol. 2007;41:918–921.
21. Polotsky VY, Patil SP, Savransky V, Laffan A, Fonti S, et al. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am J Respir Crit Care Med. 2009;179:228–234.
22. Campos GM, Bambha K, Vittinghoff E, Rabl C, Posselt AM, et al. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients. Hepatology. 2008;47:1916–1923.
23. Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA, et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;53:810–820.
24. Corey KE, Misdraji J, Zheng H, Malecki KM, Kneeman J, et al. The absence of obstructive sleep apnea may protect against non-alcoholic fatty liver in patients undergoing bariatric surgery. PLoS ONE. 2013;8:e62504.
25. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents NH, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128:S213–S256.
26. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321.
27. Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54:344–353.
28. Musso G, Cassader M, Olivetti C, Rosina F, Carbone G, et al. Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. Obes Rev. 2013;14:417–431.
29. Sookoian S, Pirola CJ. Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis. Obes Surg. 2013;23:1815–1825.
30. Corey KE, Chalasani N. Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2014;12:1077–1084.